Folpet (Pesticides)

摘要

Food Safety Commission of Japan (FSCJ) conducted a risk assessment of folpet (CAS No. 133-07-3), a phthalimide fungicide, based on results from various studies. Major adverse effects of folpet were observed in hyper-keratosis in rats and in duodenal mucosal hyperplasia in mice. No neurotoxicity and adverse effect on fertility were detected. Increases in the incidence of duodenal adenoma and adenocarcinoma were identified in carcinogenicity studies in mice. FSCJ recognized no genotoxicity relevant to human health of folpet in spite of the positive results in vitro . Therefore, a genotoxic mechanism was unlikely involved in the tumor development, and it enabled us to establish a threshold in the assessment. In developmental toxicity studies, no adverse effects observed in fetus at the dose without maternal toxicity. No folpet-induced teratogenicity was detected in rats. Folpet (parent compound only) was identified as the residue definition for dietary risk assessment in agricultural products. The lowest no-observed-adverse-effect level (NOAEL) obtained in all the studies was 10?mg/kg bw/day in several studies in dogs, rats and rabbits. FSCJ specified an acceptable daily intake (ADI) of 0.1?mg/kg bw/day by applying a safety factor of 100 to the NOAEL. The lowest NOAEL for potential adverse effects of a single oral administration of folpet was 10?mg/kg bw/day in a developmental toxicity study in rabbits. FSCJ specified an acute reference dose (ARfD) of 0.1?mg/kg bw/day, for women who are or may be pregnant, by applying a safety factor of 100 to the NOAEL. FSCJ considered it unnecessary to specify ARfD for general population.